Phenotypic transformation represents a critical mechanism underlying resistance to ALK inhibitors, primarily manifested through EMT and SCLC-like conversion, enabling tumor cells to escape ALK-dependent signaling. The gene discussed is ALK; the disease is small cell lung carcinoma.